Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,775.00p
   
  • Change Today:
      50.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 8,653
  • Market Cap: £144.99m

Regulatory News

Director Dealing 28-Apr-2025 17:13 RNS
Exercise of Options and Issue of Equity 11-Apr-2025 07:00 RNS
Interim Results 31-Mar-2025 07:00 RNS
Director Dealing 24-Dec-2024 09:14 RNS
Result of AGM 06-Dec-2024 07:00 RNS
Holding(s) in Company 04-Dec-2024 15:34 RNS
Director/PDMR Shareholding 22-Nov-2024 15:56 RNS
Notice of AGM 08-Nov-2024 07:57 RNS
Director/PDMR Shareholding 31-Oct-2024 07:00 RNS
Results for the year ended 30 June 2024 28-Oct-2024 07:00 RNS
Holding(s) in Company 25-Oct-2024 10:37 RNS
Holding(s) in Company 16-Oct-2024 13:51 RNS
Director/PDMR Shareholding 30-Apr-2024 07:00 RNS
Holding(s) in Company 12-Apr-2024 11:05 RNS
Interim Results 25-Mar-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,775.00p
Change Today 50.00p
% Change 1.83 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 8,653
Shares Issued 5.22m
Market Cap £144.99m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Trend
65.33% below the market average65.33% below the market average65.33% below the market average65.33% below the market average65.33% below the market average
21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average
Income
44.75% above the market average44.75% above the market average44.75% above the market average44.75% above the market average44.75% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
9.36% below the market average9.36% below the market average9.36% below the market average9.36% below the market average9.36% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 11-Jul-2025

Time Volume / Share Price
16:29 100 @ 2,774.00p
15:05 1,210 @ 2,752.50p
15:05 1,210 @ 2,750.00p
14:23 5 @ 2,750.00p
13:04 1,000 @ 2,751.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page